Early Histopathological Changes in New-Onset Diabetes After Kidney Transplantation

Autor: C Lengyel, Csilla Keresztes, Bernadett Borda, György Lázár, A. Kubik, Y. Munir Ibrahim, Tamás Várkonyi
Rok vydání: 2014
Předmět:
Zdroj: Transplantation Proceedings. 46:2155-2159
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2014.05.057
Popis: Background New-onset diabetes after transplantation (NODAT) is one of the most common complications after kidney transplantation. Methods Patients were randomly assigned to receive cyclosporine A–based or tacrolimus-based immunosuppression. Fasting and oral glucose tolerance tests were performed, and the patients were assigned to one of the following 3 groups, on the basis of the results: normal, impaired fasting glucose/impaired glucose tolerance, or NODAT. NODAT developed in 14% of patients receiving cyclosporine A–based immunosuppression and in 26% of patients taking tacrolimus ( P = .0002). Results Albumin levels were similar, but uric acid level ( P = .002) and the age of the recipient ( P = .003) were significantly different between the diabetic and the normal groups. Evaluation of tissue samples revealed that acute cellular rejection and interstitial fibrosis/tubular atrophy were significantly different in the NODAT group. Changes in the Banff score provided significant difference regarding tubulitis and interstitial inflammation ( P = .05). Conclusions The pathological effect of new-onset diabetes after kidney transplantation can be detected in the morphology of the renal allograft earlier, before the development of any sign of functional impairment.
Databáze: OpenAIRE